✦ LIBER ✦

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

✍ Scribed by Motzer, Robert J.; Hutson, Thomas E.; Tomczak, Piotr; Michaelson, M. Dror; Bukowski, Ronald M.; Rixe, Olivier; Oudard, Stéphane; Negrier, Sylvie; Szczylik, Cezary; Kim, Sindy T.; Chen, Isan; Bycott, Paul W.; Baum, Charles M.; Figlin, Robert A.

Book ID: 121490983
Publisher: Massachusetts Medical Society
Year: 2007
Tongue: English
Weight: 261 KB
Volume: 356
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa065044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sunitinib versus Interferon Alfa in Meta

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

✍ Coplen, D.E. 📂 Article 📅 2008 🏛 Elsevier Science ⚖ 51 KB

Re: Sunitinib versus Interferon alfa in

Re: Sunitinib versus Interferon alfa in Metastatic Renal-Cell Carcinoma

✍ Paul C.M.S. Verhagen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Cost-Effectiveness And Cost-Utility Anal

Cost-Effectiveness And Cost-Utility Analysis Of Sunitinib Versus Sorafenib And Bevacizumab + Interferon-Alfa As First-Line Treatment For Metastatic Renal Cell Carcinoma In Ecuador

✍ Torres Toala, F.G.; Albuja Riofrio, M.F.; Mould, J.F.; Estévez, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

3002 Final quality of life (QOL) results

3002 Final quality of life (QOL) results with geographical analysis for sunitinib versus interferon-alfa as first-line therapy in patients with metastatic renal cell carcinoma (mRCC)

✍ D. Cella; M.D. Michaelson; A.G. Bushmakin; J.C. Cappelleri; C. Charbonneau; S.T. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

PCN139 FINAL QUALITY OF LIFE (QOL) RESUL

PCN139 FINAL QUALITY OF LIFE (QOL) RESULTS WITH GEOGRAPHICAL ANALYSIS FOR SUNITINIB VERSUS INTERFERON-ALFA, AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)

✍ D Cella; MD Michaelson; AG Bushmakin; JC Cappelleri; C Charbonneau; ST Kim; JZ L 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

861 EFFECTS OF SUNITINIB VERSUS INTERFER

861 EFFECTS OF SUNITINIB VERSUS INTERFERON-ALFA IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): RESULTS FROM A RANDOMIZED MULTINATIONAL PHASE III TRIAL

✍ D. Cella; J.Z. Li; J.C. Cappelleri; A. Bushmakin; S.T. Kim; I. Chen; R.J. Motzer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 330 KB